Latest Patents News

AML3D has successfully commissioned its ARCEMY X system at the Tennessee Valley Authority, marking a significant milestone in its US expansion beyond defence into the energy sector.

Osteopore Limited has won tender bids to supply its innovative orthopaedic implants to two major public hospitals in Vietnam, marking a significant step in its Asia Pacific expansion.

Talga Group has begun trading on the U.S. OTCQX market, enhancing liquidity and visibility among American investors without issuing new shares. This move complements its existing listings on the ASX and Börse Frankfurt, positioning Talga for growth amid rising demand for sustainable battery materials.

Image Resources NL is broadening its project development focus beyond the newly commissioned Atlas mine, aiming to mitigate regulatory risks and ensure operational continuity through multiple potential mining projects.

FBR Limited has secured a significant $7.8 million memorandum of understanding for its Hadrian X® robotic bricklayer and launched a new DST®-enabled welding robot, Mantis, while advancing automation projects with Samsung Heavy Industries.

Identitii Limited advances its BNDRY AML platform tailored for clubs and pubs through strategic collaborations and new funding, while managing cash flow pressures and legal challenges.

Recce Pharmaceuticals advances its clinical pipeline with expanded Phase 3 trials in Indonesia and Australia, backed by a $15.8 million capital raise and a $30 million debt facility.

Nanollose Limited has completed a successful pilot manufacturing run blending its Nullarbor-20 fibre with wool, raised $1.05 million through an entitlement issue, and appointed Andrew Moullin as CEO to drive its commercialisation strategy.

IRIS Metals has successfully completed test mining at its fully permitted Beecher lithium project and expanded its US footprint with a strategic acquisition, while securing $4.27 million to fund ongoing exploration and development.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

Terragen Holdings reports rapid customer growth for its new dry probiotics, secures a US patent, and posts promising crop trial results, signaling strong momentum in its agricultural biotech offerings.

Provaris Energy has marked significant milestones in Q2 2025 with a key MOU with global shipping leader 'K' LINE and a joint venture formation with Yinson to commercialise proprietary hydrogen and carbon dioxide transport technologies.